Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.36 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.36 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8156128 | 0.98 | LPAR3 (0.47) | LPAR3LPAR1TDP1LPAR5SMPD1 | |
| SCHEMBL21291931 | 0.93 | LPAR5 (0.50) | LPAR3LPAR1TDP1LPAR5SMPD1 | |
| SCHEMBL4940484 | 0.90 | TDP1 (0.46) | LPAR3LPAR1TDP1LPAR5SMPD1 | |
| SCHEMBL6445218 | 0.90 | TDP1 (0.46) | LPAR3LPAR1TDP1LPAR5SMPD1 | |
| SCHEMBL7176541 | 0.88 | LPAR5 (0.57) | LPAR3LPAR1LPAR5SMPD1LPAR2 | |
| SCHEMBL28992600 | 0.87 | LPAR5 (0.59) | LPAR3LPAR1LPAR5SMPD1LPAR2 | |
| SCHEMBL21291920 | 0.87 | LPAR5 (0.59) | LPAR3LPAR1LPAR5SMPD1LPAR2 | |
| SCHEMBL7154075 | 0.87 | LPAR5 (0.59) | LPAR3LPAR1LPAR5SMPD1LPAR2 | |
| SCHEMBL28992598 | 0.87 | LPAR5 (0.59) | LPAR3LPAR1LPAR5SMPD1LPAR2 | |
| SCHEMBL29014861 | 0.87 | LPAR5 (0.59) | LPAR3LPAR1LPAR5SMPD1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| CN-110183603-B | Phosphorus-containing release agent, optical polymerizable composition containing same, and method for producing same | SKC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| CN-110183603-A | Phosphorous release agent, including its optics polymerizable composition, polymerizable composition and preparation method thereof | SKC株式会社 | 2019-08-30 | — | — | CN | disclosed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | disclosed |
| JP-2000281687-A | NEW PHOSPHORIC ESTER AND RELEASANT CONSISTING OF THE SAME | MITSUI CHEMICALS INC | 2000-10-10 | — | — | JP | disclosed |
| JP-2000191673-A | NEW PHOSPHORIC ACID ESTER AND MOLD RELEASING AGENT COMPRISING THE COMPOUND | MITSUI CHEMICALS INC | 2000-07-11 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | LPAR3 2839/4885LPAR1 1995/4885TDP1 3253/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | LPAR3 2839/4885LPAR1 1995/4885TDP1 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.